×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
中科院强磁场科学中心 [7]
作者
刘青松 [8]
王文超 [8]
齐紫平 [8]
王傲莉 [7]
胡晨 [6]
吴宏 [5]
更多...
发表日期
2020 [1]
2017 [4]
2016 [3]
语种
英语 [8]
出处
JOURNAL OF... [5]
ACTA PHARM... [1]
EUROPEAN J... [1]
ONCOTARGET [1]
资助项目
CAS/SAFEA ... [1]
CASHIPS Di... [1]
China Post... [1]
China Post... [1]
China Post... [1]
Frontier S... [1]
更多...
资助机构
"Hundred T... [2]
CAS/SAFEA ... [2]
China "Tho... [2]
Chinese Ac... [2]
Joint Fund... [2]
National N... [2]
更多...
收录类别
SCI [8]
摘要
文献类型
期刊论文 [8]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
(本次检索基于用户作品认领结果)
浏览/检索结果:
共8条,第1-8条
帮助
限定条件
作者:齐紫平
第一作者
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
WOS被引频次升序
WOS被引频次降序
题名升序
题名降序
作者升序
作者降序
期刊影响因子升序
期刊影响因子降序
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
作者:
Chen, Cheng
;
Cheng, Chuan-dong
;
Wu, Hong
;
Wang, Zuo-wei
;
Wang, Li
;
Jiang, Zong-ru
;
Wang, Ao-li
;
Hu, Chen
;
Dong, Yong-fei
;
Niu, Wan-xiang
;
Qi, Shuang
;
Qi, Zi-ping
;
Liu, Jing
;
Wang, Wen-chao
;
Niu, Chao-shi
;
Liu, Qing-song
浏览
  |  
Adobe PDF(3476Kb)
  |  
收藏
  |  
浏览/下载:101/36
  |  
提交时间:2020/11/26
glioblastoma
osimertinib
temozolamide
MAPK-signaling pathway
MNK
eukaryotic translation initiation factor 4E
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 20, 页码: 8407-8424
作者:
Wang, Aoli
;
Li, Xixiang
;
Chen, Cheng
;
Wu, Hong
;
Qi, Ziping
;
Hu, Chen
;
Yu, Kailin
;
Wu, Jiaxin
;
Liu, Juan
;
Liu, Xiaochuan
;
Hu, Zhenquan
;
Wang, Wei
;
Wang, Wenliang
;
Wang, Wenchao
;
Wang, Li
;
Wang, Beilei
;
Liu, Qingwang
;
Li, Lili
;
Ge, Jian
;
Ren, Tao
;
Zhang, Shanchun
;
Xia, Ruixiang
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(10028Kb)
  |  
收藏
  |  
浏览/下载:84/31
  |  
提交时间:2019/06/17
Discovery of N-(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 139, 期号: 无, 页码: 674-697
作者:
Chen, Yongfei
;
Wu, Jiaxin
;
Wang, Aoli
;
Qi, Ziping
;
Jiang, Taoshan
;
Chen, Cheng
;
Zou, Fengming
;
Hu, Chen
;
Wang, Wei
;
Wu, Hong
;
Hu, Zhenquan
;
Wang, Wenchao
;
Wang, Beilei
;
Wang, Li
;
Ren, Tao
;
Zhang, Shanchun
;
Liu, Qingsong
;
Liu, Jing
浏览
  |  
Adobe PDF(12656Kb)
  |  
收藏
  |  
浏览/下载:21282/11467
  |  
提交时间:2018/08/17
Egfr
Alk
Dual Kinase Inhibitor
Non-small Cell Lung Cancer
Discovery of 2-((3-Acrylamido-4-methylphenyl)amino)-N-(2-methyl5-(3,4,5-trimethoxybenzamido)phenyI)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-BMX-078) as a Highly Potent and Selective Type II Irreversible Bone Marrow Kinase in the X Chromosome (BMX) Kinase Inhibitor
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 5, 页码: 1793-1816
作者:
Liang, Xiaofei
;
Lv, Fengchao
;
Wang, Beilei
;
Yu, Kailin
;
Wu, Hong
;
Qi, Ziping
;
Jiang, Zongru
;
Chen, Cheng
;
Wang, Aoli
;
Miao, Weili
;
Wang, Wenchao
;
Hu, Zhenquan
;
Liu, Juan
;
Liu, Xiaochuan
;
Zhao, Zheng
;
Wang, Li
;
Zhang, Shanchuan
;
Ye, Zi
;
Wang, Chu
;
Ren, Tao
;
Wang, Yinsheng
;
Liu, Qingsong
;
Liu, Jing
浏览
  |  
Adobe PDF(5919Kb)
  |  
收藏
  |  
浏览/下载:17302/7525
  |  
提交时间:2018/07/04
Discovery of 4-Methyl-N-(44(4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-y1)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 1, 页码: 273-289
作者:
Wang, Qiang
;
Liu, Feiyang
;
Wang, Beilei
;
Zou, Fengming
;
Qi, Ziping
;
Chen, Cheng
;
Yu, Kailin
;
Hu, Chen
;
Qi, Shuang
;
Wang, Wenchao
;
Hu, Zhenquan
;
Liu, Juan
;
Wang, Wei
;
Wang, Li
;
Liang, Qianmao
;
Zhang, Shanchun
;
Ren, Tao
;
Liu, Qingsong
;
Liu, Jing
浏览
  |  
Adobe PDF(3516Kb)
  |  
收藏
  |  
浏览/下载:106/58
  |  
提交时间:2018/07/04
Discovery of N-((1-(4-(3-(3-((6,7-Dimethoxyquinolin-3-yl)oxy)phenyl)ureido)-2-(trifluoromethyl)phenyl)piperidin-4-yl)methyl)propionamide (CHMFL-KIT-8140) as a Highly Potent Type II Inhibitor Capable of Inhibiting the T670I "Gatekeeper" Mutant of cKIT Kinase
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 18, 页码: 8456-8472
作者:
Li, Binhua
;
Wang, Aoli
;
Liu, Juan
;
Qi, Ziping
;
Liu, Xiaochuan
;
Yu, Kailin
;
Wu, Hong
;
Chen, Cheng
;
Hu, Chen
;
Wang, Wenchao
;
Wu, Jiaxin
;
Hu, Zhenquan
;
Ye, Ling
;
Zou, Fengming
;
Liu, Feiyang
;
Wang, Beilei
;
Wang, Li
;
Ren, Tao
;
Zhang, Shaojuan
;
Bai, Mingfeng
;
Zhang, Shanchun
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(2856Kb)
  |  
收藏
  |  
浏览/下载:1410/1299
  |  
提交时间:2017/11/21
Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML)
期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: 29, 页码: 45562-45574
作者:
Liu, Feiyang
;
Wang, Beilei
;
Wang, Qiang
;
Qi, Ziping
;
Chen, Cheng
;
Kong, Lu-Lu
;
Chen, Ji-Yun
;
Liu, Xiaochuan
;
Wang, Aoli
;
Hu, Chen
;
Wang, Wenchao
;
Wang, Huiping
;
Wu, Fan
;
Ruan, Yanjie
;
Qi, Shuang
;
Liu, Juan
;
Zou, Fengming
;
Hu, Zhenquan
;
Wang, Wei
;
Wang, Li
;
Zhang, Shanchun
;
Yun, Cai-Hong
;
Zhai, Zhimin
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(8054Kb)
  |  
收藏
  |  
浏览/下载:254/200
  |  
提交时间:2017/11/21
Bcr-abl
Pdgfr
Chronic Myeloid Leukemia
Kinase Inhibitor
Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 5, 页码: 1984-2004
作者:
Liang, Xiaofei
;
Liu, Xiaochuan
;
Wang, Beilei
;
Zou, Fengming
;
Wang, Aoli
;
Qi, Shuan
;
Chen, Cheng
;
Zhao, Zheng
;
Wang, Wenchao
;
Qi, Ziping
;
Lv, Fengchao
;
Hu, Zhenquan
;
Wang, Li
;
Zhang, Shanchun
;
Liu, Qingsong
;
Liu, Jing
浏览
  |  
Adobe PDF(3635Kb)
  |  
收藏
  |  
浏览/下载:13709/5312
  |  
提交时间:2017/11/06